Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:16 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 7:16 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Procter & Gamble (PG) a Smart Investment Pre-Q4 Earnings?
by Rajani Lohia
While P&G's (PG) strong financial performance and strategic initiatives provide a solid foundation for growth in Q4, the external risks justify a neutral stance on its investment potential.
Church & Dwight (CHD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Vita Coco Company (COCO) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Vita Coco Company's (COCO) second-quarter 2024 results are likely to reflect gains from brand strength and share in the coconut water category.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Archer Daniels (ADM) Gears Up for Q2 Earnings: Things to Note
by Zacks Equity Research
Archer Daniels' (ADM) second-quarter 2024 results are likely to reflect the impacts of tough market conditions and higher costs. A soft Nutrition segment is also a concern.
Sysco's (SYY) Q4 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Sysco's (SYY) Q4 results are likely to reflect gains from the company's efforts to enhance volumes and improve efficiency through supply-chain productivity and cost-containment efforts.
Mondelez (MDLZ) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Mondelez's (MDLZ) Q2 results are likely to reflect the impacts of a tough operating landscape and input cost inflation, while pricing is likely to have aided the performance.
Will Strong Volume & Pricing Aid Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Solid volume and pricing, and growth across categories and regions are likely to aid Colgate's (CL) Q2 results. Softness in China, high raw material costs and FX inflation are concerning.
Will Lamb Weston (LW) Top Estimates in Q4 Earnings Release?
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter results are likely to reflect gains from a favorable pricing environment amid volume concerns.
Columbia Sportswear (COLM) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Columbia Sportswear's (COLM) Q2 results are likely to reflect the impacts of a tough operating landscape in North America, leading to soft demand, along with high SG&A costs.
Procter & Gamble (PG) Hits 52-Week High: Buy, Hold or Sell?
by Rajani Lohia
After Procter & Gamble (PG) hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Clorox (CLX) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
5 Well-Placed Stocks in a Prospering Soap & Cleaning Materials Industry
by Rajani Lohia
Pricing initiatives, innovation, digital transformation and brand building are crucial to the success of companies in the soap and cleaning materials industry, especially amid rising costs. Companies like PG, CL, HENKY, CHD, and CLX are well-positioned to thrive through these efforts.
Clorox's (CLX) Pricing & Cost Saving on Track: Apt to Hold?
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Will Clorox (CLX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Conagra Brands (CAG) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Conagra Brands' (CAG) fourth-quarter performance is likely to reflect lower volumes due to an industry-wide slowdown in consumption.
Helen of Troy (HELE) Q1 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Can Constellation Brands (STZ) Beat Q1 Earnings Amid High Costs?
by Zacks Equity Research
Constellation Brands' (STZ) Q1 results are likely to reflect gains from a strong beer portfolio, growth in Power Brands and premiumization. Inflationary costs are expected to have weighed on margins.
McCormick (MKC) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
McCormick's (MKC) second-quarter performance is likely to reflect the adverse impact of lower volumes and inflationary headwinds. Also, rising SG&A costs are a concern.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.